Profile | GDS5420 / 212729_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 619.76 | 71 |
GSM1296119 | B_lesional_pre-dose | 637.96 | 72 |
GSM1296076 | C_lesional_pre-dose | 929.16 | 78 |
GSM1296092 | D_lesional_pre-dose | 804.12 | 75 |
GSM1296103 | E_lesional_pre-dose | 650.84 | 72 |
GSM1296078 | F_lesional_pre-dose | 898.65 | 78 |
GSM1296107 | G_lesional_pre-dose | 563.57 | 70 |
GSM1296109 | H_lesional_pre-dose | 671.47 | 72 |
GSM1296080 | I_lesional_pre-dose | 307.99 | 60 |
GSM1296090 | J_lesional_pre-dose | 974.95 | 78 |
GSM1296074 | K_lesional_pre-dose | 1061.85 | 80 |
GSM1296111 | L_lesional_pre-dose | 626.82 | 72 |
GSM1296099 | M_lesional_pre-dose | 535.89 | 69 |
GSM1296086 | O_lesional_pre-dose | 475.06 | 67 |
GSM1296117 | P_lesional_pre-dose | 746.26 | 75 |
GSM1296113 | Q_lesional_pre-dose | 700.54 | 73 |
GSM1296096 | R_lesional_pre-dose | 733.66 | 74 |
GSM1296105 | S_lesional_pre-dose | 386.12 | 63 |
GSM1296098 | T_lesional_pre-dose | 433.58 | 65 |
GSM1296101 | U_lesional_pre-dose | 402.59 | 64 |
GSM1296121 | V_lesional_pre-dose | 565.68 | 70 |
GSM1296088 | W_lesional_pre-dose | 531.48 | 69 |
GSM1296082 | X_lesional_pre-dose | 1144.38 | 81 |
GSM1296115 | Y_lesional_pre-dose | 933.94 | 78 |
GSM1296084 | Z_lesional_pre-dose | 361.04 | 62 |
GSM1296072 | B_lesional_day8 | 420.78 | 65 |
GSM1296069 | L_lesional_day8 | 301.04 | 58 |
GSM1296071 | P_lesional_day8 | 419.98 | 64 |
GSM1296070 | Y_lesional_day8 | 614.66 | 71 |
GSM1296073 | V_lesional_day8 | 852.44 | 77 |
GSM1296034 | A_lesional_day15 | 267.24 | 56 |
GSM1296041 | G_lesional_day15 | 1048.23 | 80 |
GSM1296035 | R_lesional_day15 | 728.3 | 74 |
GSM1296038 | U_lesional_day15 | 427.49 | 65 |
GSM1296047 | B_lesional_day15 | 363.75 | 62 |
GSM1296039 | E_lesional_day15 | 917.59 | 78 |
GSM1296042 | H_lesional_day15 | 458.5 | 66 |
GSM1296043 | L_lesional_day15 | 429.71 | 64 |
GSM1296037 | M_lesional_day15 | 295.85 | 58 |
GSM1296046 | P_lesional_day15 | 484.32 | 67 |
GSM1296044 | Q_lesional_day15 | 369.23 | 62 |
GSM1296045 | Y_lesional_day15 | 509.29 | 68 |
GSM1296025 | C_lesional_day15 | 211.95 | 54 |
GSM1296033 | D_lesional_day15 | 322.66 | 60 |
GSM1296027 | I_lesional_day15 | 184.73 | 53 |
GSM1296032 | J_lesional_day15 | 329.34 | 60 |
GSM1296024 | K_lesional_day15 | 186.2 | 52 |
GSM1296031 | W_lesional_day15 | 297.77 | 58 |
GSM1296028 | X_lesional_day15 | 285.15 | 58 |
GSM1296029 | Z_lesional_day15 | 225.04 | 54 |
GSM1296026 | F_lesional_day15 | 441.16 | 66 |
GSM1296030 | O_lesional_day15 | 292.31 | 60 |
GSM1296040 | S_lesional_day15 | 465.1 | 66 |
GSM1296036 | T_lesional_day15 | 366.48 | 62 |
GSM1296048 | V_lesional_day15 | 643.34 | 72 |
GSM1296059 | A_lesional_day43 | 637.92 | 72 |
GSM1296066 | G_lesional_day43 | 575.61 | 70 |
GSM1296060 | R_lesional_day43 | 481.13 | 67 |
GSM1296063 | U_lesional_day43 | 718.95 | 74 |
GSM1296064 | E_lesional_day43 | 1193.07 | 82 |
GSM1296067 | H_lesional_day43 | 248.5 | 54 |
GSM1296062 | M_lesional_day43 | 340.89 | 61 |
GSM1296068 | Q_lesional_day43 | 313.83 | 58 |
GSM1296050 | C_lesional_day43 | 326.8 | 61 |
GSM1296057 | D_lesional_day43 | 471.22 | 66 |
GSM1296052 | I_lesional_day43 | 163.05 | 50 |
GSM1296054 | J_lesional_day43 | 289.63 | 58 |
GSM1296049 | K_lesional_day43 | 249.16 | 56 |
GSM1296055 | W_lesional_day43 | 345.59 | 61 |
GSM1296053 | X_lesional_day43 | 159.3 | 49 |
GSM1296058 | Z_lesional_day43 | 363.6 | 62 |
GSM1296051 | F_lesional_day43 | 539.42 | 70 |
GSM1296056 | O_lesional_day43 | 917.12 | 78 |
GSM1296065 | S_lesional_day43 | 713.26 | 73 |
GSM1296061 | T_lesional_day43 | 375.63 | 62 |
GSM1296095 | A_non-lesional_pre-dose | 508.28 | 68 |
GSM1296120 | B_non-lesional_pre-dose | 380.22 | 63 |
GSM1296077 | C_non-lesional_pre-dose | 323.11 | 61 |
GSM1296093 | D_non-lesional_pre-dose | 180.17 | 50 |
GSM1296104 | E_non-lesional_pre-dose | 486.85 | 67 |
GSM1296079 | F_non-lesional_pre-dose | 273.03 | 58 |
GSM1296108 | G_non-lesional_pre-dose | 335.56 | 61 |
GSM1296110 | H_non-lesional_pre-dose | 310.61 | 58 |
GSM1296081 | I_non-lesional_pre-dose | 220.08 | 55 |
GSM1296091 | J_non-lesional_pre-dose | 655.58 | 72 |
GSM1296075 | K_non-lesional_pre-dose | 358.84 | 63 |
GSM1296112 | L_non-lesional_pre-dose | 365.17 | 61 |
GSM1296100 | M_non-lesional_pre-dose | 369.09 | 62 |
GSM1296087 | O_non-lesional_pre-dose | 235.81 | 57 |
GSM1296118 | P_non-lesional_pre-dose | 368.06 | 62 |
GSM1296114 | Q_non-lesional_pre-dose | 299.35 | 58 |
GSM1296097 | R_non-lesional_pre-dose | 327.8 | 60 |
GSM1296106 | S_non-lesional_pre-dose | 373.29 | 62 |
GSM1296102 | U_non-lesional_pre-dose | 155.84 | 47 |
GSM1296122 | V_non-lesional_pre-dose | 266.59 | 56 |
GSM1296089 | W_non-lesional_pre-dose | 318.19 | 59 |
GSM1296083 | X_non-lesional_pre-dose | 156.25 | 48 |
GSM1296116 | Y_non-lesional_pre-dose | 362.45 | 61 |
GSM1296085 | Z_non-lesional_pre-dose | 317.79 | 60 |